RxDoctor Payments Data

Cynthia Drury, MD

Family Medicine · Pelham, GANPI 1194790626

Payments from drug & device makers

$6,399in general payments, 2019–2025

Across 379 payments — averaging $16.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$1K
  • Novo Nordisk$982
  • Boehringer Ingelheim$763
  • AstraZeneca$580
  • Lilly USA, LLC$548
  • AbbVie$384
  • plus $2K from 22 others

What the payments were for

  • Food & beverage$6,387100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,399 in reported general payments places this provider in the 85th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$30,116
Medicare patients
75
Services billed
545

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide93$89,803
FarxigaDapagliflozin Propanediol63$66,733
JardianceEmpagliflozin60$59,047
EliquisApixaban51$54,835
OzempicSemaglutide53$51,401
MounjaroTirzepatide36$43,869
JanuviaSitagliptin Phosphate42$42,784
LinzessLinaclotide45$42,351
ProliaDenosumab12$20,906
XareltoRivaroxaban15$20,019
Breo ElliptaFluticasone/Vilanterol40$19,984
MyrbetriqMirabegron14$14,466
RybelsusSemaglutide13$14,032
EntrestoSacubitril/Valsartan21$12,853
Repatha SureclickEvolocumab12$6,781

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$548$133,672129 claims
AstraZenecaFarxiga, Symbicort$580$69,86177 claims
Novo NordiskOzempic, Rybelsus$982$65,43466 claims
Boehringer IngelheimJardiance$763$59,04760 claims
PfizerEliquis, Prempro$149$56,38562 claims
MerckJanuvia$242$42,78442 claims
AbbVieLinzess$384$42,35145 claims
AmgenProlia$340$20,90612 claims
Johnson & JohnsonXarelto$158$20,01915 claims
GSKBreo Ellipta$1,125$19,98440 claims
Astellas Pharma US IncMyrbetriq$33$14,46614 claims
NovartisEntresto$84$12,85321 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Pelham

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →